Chinese herbs in the treatment of laparoscopy diagnosed endometriosis: a controlled study.
A randomised double-blind placebo controlled clinical trial of the use of Chinese herbal medicine in the management of endometriosis.
University of Western Sydney
150 participants
Jun 1, 2004
Interventional
Conditions
Summary
The study is a randomised, double-blind, multi-centre clinical trial to evaluate the use of Chinese herbal medicine in the management of endometriosis. Formulated Chinese herbs will be assessed against an inert placebo. Trial participants will be randomly allocated to either Chinese herbal medicine or placebo. Neither participants nor researchers/assessors will have knowledge of the allocation. It is a prospective clinical study in which participants are reviewed monthly for six months, and three month follow up. Stringent methodology includes an objective laparoscopy diagnosis of endometriosis and suitable outcome measures. The study also includes ensuring participants completing the trial and, facilitating consistent data collection and validity. The trial will be a multi-centre clinical trial with participants recruited and reviewed at several health centres. This will be the first clinical trial in Australia combining Chinese herbal medicine, an objective diagnosis (laparoscopy) and a strict methodological protocol.
Eligibility
Plain Language Summary
Simplified for easier understanding
This summary was AI-generated to explain the trial in plain language. It is not medical advice. Always discuss eligibility with your doctor before enrolling in a clinical trial.
Interested in this trial?
Get notified about updates and connect with the research team.
Interventions
Chinese herbal medicine extract in oral capsule form, with a dosage of 4 capsules twice daily for six months. The formulation ingredients remain commercial-in-confidence.
Locations(1)
View Full Details on ANZCTR
For the most up-to-date information, visit the official listing.
ACTRN12608000619347